Dignitana AB Publishes Q1 2022 Interim Report
Solid growth trend continues at 21 percent Financial highlights Q1 2022 · Net sales amounted to 15.9 MSEK (13.2), an increase of 21 percent over the same period in 2021. · Operating result amounted to -6.1 MSEK (-7.1). ·Net result after financial items amounted to -6.5 MSEK (-7.7). ·Earnings per share were -0,10 SEK (-0,12). ·Cash Balance amounted to 11.3 MSEK (44.4). ·Average Daily Treatment Revenue (ADTR)* was 179 TSEK (130), an increase of 38 percent over the same period in 2021. Significant events during the period ·The Board appointed